Horn & Co. represented VBL Therapeutics on the deal. VBL Therapeutics executed the merger with Notable Labs. The merger aims to create Nasdaq-listed, clinical-stage therapeutic platform company developing new...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised Pangea on the deal. Pangea executed a seed investment round. Pangea Biomed is a multi-cancer response predictor improving the effectiveness of precision oncology....
You must be a Standard 1 Year member to access this content.
Horn & Co. represented Nanosynex Ltd. in the deal. Qualigen Therapeutics, Inc. has completed the acquisition of a majority stake in NanoSynex Ltd., an Israeli-based developer...
You must be a Standard 1 Year member to access this content.
Horn & Co. advised Zebra Medical Vision on the deal. APM&Co represented NANO-X IMAGING Ltd on the deal. Zebra Medical Vision Ltd. executed a $200 million merger...
You must be a Standard 1 Year member to access this content.
